Phase 2 findings
Performance Summary
During Phase 2 (March 2023 to February 2024) we investigated the performance of a number of NFCS. We sought information from all of the multinational NFCS (coverage shown in blue) and from the national NFCS (shown in red).
We sent out online surveys looking at:-
| Who made the claims? | Was it the vaccine injured individual? A representative? A lawyer? We asked a number of demographic questions including:- claimant age, gender, ethnicity, healthcare professional status |
| How claims were processed? | How many claims were accepted? How many rejected? How many carried forward? What was the average claim processing time? |
| Value of Awards? | The average, maximum and minimum award values, indicating the range of values |
| Appeals | How many appeals were made? How many were successful? |
We also asked about how potential claimants could find information out about the NFCS.
We are very grateful to the NFCS that did respond to our survey, despite extensive follow up, it was a lower proportion than we would have liked.
The following report details our findings.